Search
× Search

Non-Allergic Rhinitis (Vasomotor)

Non-Allergic Rhinitis (Vasomotor)

Non-allergic rhinitis is a chronic condition that can occur at any age but is more common in adults. The most common symptoms are nasal congestion, post-nasal drainage, and headache, although runny nose, sneezing and itching of the nose may occur in some non-allergic individuals. Many non-allergic patients have recurrent sinusitis and middle ear infections or middle ear fluid collection.

Initial evaluation requires that surgical conditions (growths in the nose, crooked nasal septum, etc.) and general medical conditions (thyroid disease, pregnancy, etc.) are not responsible for the chronic symptoms. We recommend that ever patient have a family practitioner, internist, or pediatrician to follow them for their general medical care. If the history and physical examination are not positive for surgical or general medical problems, the patient most likely has the most common nasal problem of non-allergic or allergic nasal disease.

Non-allergic rhinitis is a very difficult topic to fully understand. The actual defect resulting in the symptoms commonly found is not known. We do know that the difficulty arises in the inability to correctly change the size of blood vessels and the quantity of mucus produced by mucus glands in the nose. Under normal circumstances the nose warms or cools the air entering the nose to 98 degrees F., increases the humidity to at least 80%, and filters unwanted substances resulting in relatively clean air at 98 degrees F. and 80% humidity entering the lungs regardless of current environmental conditions. These changes occur almost instantly with each breath. The non-allergic individual has lost the ability to make the necessary changes either from an ineffective blood vessel and mucus gland controlling mechanism, temperature and humidity sensing mechanism, or both. The end result is inappropriate blood vessel size and/or excess mucus production which can result in nasal congestion, post-nasal drainage, and headaches.

Many individuals with non-allergic nasal disease will have a significant amount of irritation, inflammation, and hyperreactivity in the nose contributing to the persistent, chronic nature of the disease.

Nasal allergy on the other hand usually presents with runny nose, sneezing, and itching but some patients can also have nasal congestion, post-nasal drainage, and headaches. With nasal allergy we usually see definite problems at certain seasons of the year or a correlation with exposures to dust, animal dander, mold or mildew exposures and in some patients’ extreme reactions to certain foods. Allergy symptoms also involving the eyes usually are redness, itching and watering of the eyes.

It is possible for an individual to have problems with both non-allergic rhinitis and allergic rhinitis, and this makes the problems at times more difficult to clearly diagnose and treat.

Several tests can be used to differentiate non-allergic rhinitis from allergic rhinitis. Skin testing, as one might expect, displays positivity in patients with allergic rhinitis, whereas a negative skin test will be obtained in patients with non-allergic rhinitis. In addition, the blood IgE levels and eosinophils (the allergy cell) are elevated in patients with allergic rhinitis but not in non-allergic rhinitis.

Non-allergic rhinitis often is triggered by drafts, temperature changes (especially cold air), by scented cosmetics (both men’s and women’s cosmetics), by cigarette and tobacco smoke, as well as fireplace smoke, scented or perfumed soaps. Many types of aerosol sprays, even scented deodorants can cause problems. Paint fumes, insecticides, bug sprays,
varnishes, and even the odor from new clothing, carpeting or furniture can cause problems. Kerosene, lighter fluids, oil and gas fumes can cause problems. House dust may act as an irritant, and should be avoided.

Do not overuse over-the-counter decongestant sprays or nose drops because these can cause “rebound” nasal congestion. All nasal decongestant sprays should be discontinued following 3 days of continuous use. Medications will be prescribed to help with this problem. A good part of the treatment is avoiding known problems and exposures, and working by trial and error to find medications that work best in your case. Medications that may be tried include: Astelin© nasal spray, decongestants, decongestant-antihistamine combinations, intranasal steroid sprays, and possibly an atropine-derivative nasal spray (Atrovent©).

Recent News

SuperUser Account
/ Categories: News

AAFA’s 2024 Allergy Capitals™ report names most challenging cities for living with allergies, OKC – Fifth; Tulsa – Sixth in the top Ten

Washington D.C., March 14, 2024 — The Asthma and Allergy Foundation of America (AAFA) released its 2024 Allergy Capitals™ report detailing the most challenging cities in the United States for living with allergies. The full report can be found at allergycapitals.com.

This year, Wichita, Kansas takes the top spot due to its higher-than-average tree and grass pollen, higher-than-average medicine use, and limited access to allergy specialists. The top 10 Allergy Capitals™ for 2024 are: 1. Wichita, KS; 2. Virginia Beach, VA; 3. Greenville, SC; 4. Dallas, TX; 5. Oklahoma City, OK; 6. Tulsa, OK; 7. Richmond, VA 8. Des Moines, IA; 9. Raleigh, NC, and 10. Fayetteville, AR.

This year’s report again calls attention to the urgency of the climate crisis. Due to climate change, growing seasons start earlier and last longer than they did just 30 years ago. Some parts of the United States now experience pollen (tree, grass, or weed) year-round. Warmer temperatures also trap heat in urban areas, increase air pollution, and stimulate pollen production.

“Climate change fuels a perfect storm of conditions that make allergy season worse for people with pollen allergy,” said AAFA President and CEO Kenneth Mendez. “Longer growing seasons mean more exposure to pollen allergy triggers. Additionally, pollen counts tend to rise with warmer temperatures. Now, we see both more days of exposure to pollen and higher daily pollen counts leading to more intense, longer-lasting symptoms.”

AAFA’s 2024 Allergy Capitals™ report provides insight into factors impacting seasonal allergies. The report ranks the 100 most populous cities in the contiguous United States by their:

  • Tree, grass, and weed pollen scores
  • Over-the-counter allergy medicine use
  • Availability of board-certified allergists/immunologists 

Experts say a range of treatment options are available for people dealing with seasonal allergies this spring.

“Over-the-counter medicines can help manage symptoms,” said allergist Dr. Neeta Ogden, spokesperson for AAFA. “Working with a specialist can help you develop the best treatment plan.”

While the symptoms of pollen allergy can be managed, they are a significant health concern. Seasonal allergies can even lead to hospitalization if they trigger an asthma episode.

“Our pollen season continues to begin earlier each year,” said Dr. Claire Atkinson, a board-certified allergist with the Oklahoma Allergy & Asthma Clinic (OAAC). “We’ve already had several allergy alert days this year and we’ve not even made it to the official start of Spring. We want to encourage people who are suffering to see their medical provider and consider making an appointment with an allergist.”

A board-certified allergist can diagnose allergies, and determine the specific triggers that cause them, through simple tests. The allergists at OAAC evaluate and manage patients of all ages. The main clinic is on the Oklahoma Health Center campus. For patient convenience, satellite offices are in Edmond, Norman and Yukon.

Visit the OAAC website at www.oklahomaallergy.com to view the addresses for all Oklahoma Allergy and Asthma Clinic locations. To make an initial appointment or to request more information, please call (405) 235-0040 or visit the website.

For information on preventing and treating allergies and asthma, visit aafa.org.

The post AAFA’s 2024 Allergy Capitals™ report names most challenging cities for living with allergies, OKC – Fifth; Tulsa – Sixth in the top Ten appeared first on Oklahoma Allergy and Asthma Clinic.

Previous Article FDA Approves Takeda’s EOHILIA (budesonide oral suspension), the First and Only Oral Treatment in the U.S. for Eosinophilic Esophagitis (EoE)
Next Article Asthma Triggers
Print
240
Terms Of UsePrivacy StatementCopyright 2026 by Oklahoma Allergy and Asthma Clinic
Back To Top